Recent Advances in Nanotechnology-Aided Materials in Combating Microbial Resistance and Functioning as Antibiotics Substitutes

References

• Fischbach MA, Walsh CT. Antibiotics for emerging pathogens. Science. 2009;325(5944):1089–1093. doi:10.1126/science.117666719713519
   PubMed Web of Science ®Google Scholar
• Linares JF, Gustafsson I, Baquero F, Martinez JL. Antibiotics as intermicrobial signaling agents instead of weapons. Proc Natl Acad Sci. 2006;103(51):19484–19489. doi:10.1073/pnas.060894910317148599
   PubMed Web of Science ®Google Scholar
• Peschel A, Sahl H-G. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat Rev Microbiol. 2006;4(7):529–536. doi:10.1038/nrmicro144116778838
   PubMed Web of Science ®Google Scholar
• Initiative AR, Initiative PAAR. Detect and Protect Against Antibiotic Resistance.
   Google Scholar
• Willyard C. The drug-resistant bacteria that pose the greatest health threats. Nat News. 2017;543(7643):15. doi:10.1038/nature.2017.21550
   Web of Science ®Google Scholar
• Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: a global multifaceted phenomenon. Pathogens Glob Health. 2015;109(7):309–318. doi:10.1179/2047773215Y.0000000030
   PubMed Web of Science ®Google Scholar
• Laxminarayan R, Duse A, Wattal C, et al. Antibiotic resistance—the need for global solutions. Lancet Infect Dis. 2013;13(12):1057–1098. doi:10.1016/S1473-3099(13)70318-924252483
   PubMed Web of Science ®Google Scholar
• Chambers HF. The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis. 2001;7(2):178. doi:10.3201/eid0702.01020411294701
   PubMed Web of Science ®Google Scholar
• Lister PD, Wolter DJ, Hanson ND. Antibacterial-resistant pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev. 2009;22(4):582–610.19822890
   PubMed Web of Science ®Google Scholar
• Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. Global challenge of multidrug-resistant acinetobacter baumannii. Antimicrob Agents Chemother. 2007;51(10):3471–3484. doi:10.1128/AAC.01464-0617646423
   PubMed Web of Science ®Google Scholar
• Wright GD. Mechanisms of resistance to antibiotics. Curr Opin Chem Biol. 2003;7(5):563–569. doi:10.1016/j.cbpa.2003.08.00414580559
   PubMed Web of Science ®Google Scholar
• Neu HC. The crisis in antibiotic resistance. Science. 1992;257(5073):1064–1073. doi:10.1126/science.257.5073.10641509257
   PubMed Web of Science ®Google Scholar
• Berger-Bächi B. Expression of resistance to methicillin. Trends Microbiol. 1994;2(10):389–393. doi:10.1016/0966-842X(94)90617-37850207
   PubMedGoogle Scholar
• Rolain JM, Parola P, Cornaglia G. New Delhi metallo-beta-lactamase (NDM-1): towards a new pandemia? Clin Microbiol Infect. 2010;16(12):1699–1701. doi:10.1111/j.1469-0691.2010.03385.x20874758
   PubMed Web of Science ®Google Scholar
• Devaux I, Kremer K, Heersma H, Van Soolingen D. Clusters of multidrug-resistant mycobacterium tuberculosis cases, Europe. Emerg Infect Dis. 2009;15(7):1052. doi:10.3201/eid1507.08099419624920
   PubMed Web of Science ®Google Scholar
• Hajipour MJ, Fromm KM, Ashkarran AA, et al. Antibacterial properties of nanoparticles. Trends Biotechnol. 2012;30(10):499–511. doi:10.1016/j.tibtech.2012.06.00422884769
   PubMed Web of Science ®Google Scholar
• Schröfel A, Kratošová G, Šafařík I, Šafaříková M, Raška I, Shor LM. Applications of biosynthesized metallic nanoparticles–a review. Acta Biomater. 2014;10(10):4023–4042. doi:10.1016/j.actbio.2014.05.02224925045
   PubMed Web of Science ®Google Scholar
• Zhang L, Pornpattananangkul D, Hu C-M, Huang C-M. Development of nanoparticles for antimicrobial drug delivery. Curr Med Chem. 2010;17(6):585–594. doi:10.2174/09298671079041629020015030
   PubMed Web of Science ®Google Scholar
• Gupta A, Mumtaz S, Li CH, Hussain I, Rotello VM. Combatting antibiotic-resistant bacteria using nanomaterials. Chem Soc Rev. 2019;48(2):415–427. doi:10.1039/c7cs00748e.30462112
   PubMed Web of Science ®Google Scholar
• Huh AJ, Kwon YJ. “Nanoantibiotics”: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. J Control Release. 2011;156(2):128–145. doi:10.1016/j.jconrel.2011.07.00221763369
   PubMed Web of Science ®Google Scholar
• Miller KP, Wang L, Benicewicz BC, Decho AW. Inorganic nanoparticles engineered to attack bacteria. Chem Soc Rev. 2015;44(21):7787–7807.26190826
   PubMed Web of Science ®Google Scholar
• Blair JMA, Webber MA, Baylay AJ, Ogbolu DO, Piddock LJV. Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol. 2015;13(1):42–51. doi:10.1038/nrmicro338025435309
   PubMed Web of Science ®Google Scholar
• Davies J, Davies D. Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev. 2010;74(3):417–433. doi:10.1128/MMBR.00016-1020805405
   PubMed Web of Science ®Google Scholar
• Jayaraman R. Antibiotic resistance: an overview of mechanisms and a paradigm shift. Curr Sci. 2009;1475–1484.
   Web of Science ®Google Scholar
• Livermore DM. Bacterial resistance: origins, epidemiology, and impact. Clin Infect Dis. 2003;36(Supplement_1):S11–S23. doi:10.1086/34465412516026
   PubMedGoogle Scholar
• Poole K. Mechanisms of bacterial biocide and antibiotic resistance. J Appl Microbiol. 2002;92(s1):55S–64S. doi:10.1046/j.1365-2672.92.5s1.8.x12000613
   PubMed Web of Science ®Google Scholar
• Caro RDC, Cannizzaro MV, Botti E, et al. Clindamycin versus clindamycin plus rifampicin in hidradenitis suppurativa treatment: clinical and ultrasound observations. J Am Acad Dermatol. 2019;80(5):1314–1321. doi:10.1016/j.jaad.2018.11.03530502416
   PubMed Web of Science ®Google Scholar
• Quintiliani R. Using pharmacodynamic and pharmacokinetic concepts to optimize treatment of infectious diseases. Infect Med. 2004;21(5):219–232.
   Google Scholar
• Bernier SP, Surette MG. Concentration-dependent activity of antibiotics in natural environments. Front Microbiol. 2013;4:20. doi:10.3389/fmicb.2013.0002023422936
   PubMed Web of Science ®Google Scholar
• Wright GD. Molecular mechanisms of antibiotic resistance. Chem Commun. 2011;47(14):4055–4061. doi:10.1039/c0cc05111j
   PubMed Web of Science ®Google Scholar
• Nikaido H. Multidrug resistance in bacteria. Annu Rev Biochem. 2009;78(1):119–146. doi:10.1146/annurev.biochem.78.082907.14592319231985
   PubMed Web of Science ®Google Scholar
• Du D, Wang-Kan X, Neuberger A, et al. Multidrug efflux pumps: structure, function and regulation. Nat Rev Microbiol. 2018;16(9):523–539. doi:10.1038/s41579-018-0048-630002505
   PubMed Web of Science ®Google Scholar
• Vargiu AV, Nikaido H. Multidrug binding properties of the ACRB efflux pump characterized by molecular dynamics simulations. Proc Natl Acad Sci. 2012;109(50):20637–20642. doi:10.1073/pnas.121834810923175790
   PubMed Web of Science ®Google Scholar
• Siegel SD, Liu J, Ton-That H. Biogenesis of the gram-positive bacterial cell envelope. Curr Opin Microbiol. 2016;34:31–37. doi:10.1016/j.mib.2016.07.01527497053
   PubMed Web of Science ®Google Scholar
• Appelbaum PC, Jacobs MR. Recently approved and investigational antibiotics for treatment of severe infections caused by gram-positive bacteria. Curr Opin Microbiol. 2005;8(5):510–517. doi:10.1016/j.mib.2005.07.00116098786
   PubMed Web of Science ®Google Scholar
• Deck DH, Winston LG. Sulfonamides, trimethoprim, quinolones. Basic Clin Pharmacol. 2012.
   Google Scholar
• Povolo VR, Ackermann M. Disseminating antibiotic resistance during treatment. Science. 2019;364(6442):737–738. doi:10.1126/science.aax662031123125
   PubMed Web of Science ®Google Scholar
• Yamasaki S, Nikaido E, Nakashima R, et al. The crystal structure of multidrug-resistance regulator RAMR with multiple drugs. Nat Commun. 2013;4(1):1–7. doi:10.1038/ncomms3078
   Google Scholar
• Moyá B, Beceiro A, Cabot G, et al. Pan-β-lactam resistance development in pseudomonas aeruginosa clinical strains: molecular mechanisms, penicillin-binding protein profiles, and binding affinities. Antimicrob Agents Chemother. 2012;56(9):4771–4778. doi:10.1128/AAC.00680-1222733064
   PubMed Web of Science ®Google Scholar
• Chang S, Sievert DM, Hageman JC, et al. Infection with vancomycin-resistant staphylococcus aureus containing the vana resistance gene. N Engl J Med. 2003;348(14):1342–1347. doi:10.1056/NEJMoa02502512672861
   PubMed Web of Science ®Google Scholar
• Achari A, Somers DO, Champness JN, Bryant PK, Rosemond J, Stammers DK. Crystal structure of the anti-bacterial sulfonamide drug target dihydropteroate synthase. Nat Struct Biol. 1997;4(6):490–497. doi:10.1038/nsb0697-4909187658
   PubMedGoogle Scholar
• Zignol M, Cabibbe AM, Dean AS, et al. Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study. Lancet Infect Dis. 2018;18(6):675–683. doi:10.1016/S1473-3099(18)30073-229574065
   PubMed Web of Science ®Google Scholar
• Rodríguez-Martínez JM, Briales A, Velasco C, Conejo MC, Martínez-Martínez L, Pascual A. Mutational analysis of quinolone resistance in the plasmid-encoded pentapeptide repeat proteins QnrA, QnrB and QnrS. J Antimicrob Chemother. 2009;63(6):1128–1134. doi:10.1093/jac/dkp11119357158
   PubMed Web of Science ®Google Scholar
• Gatermann SG, Koschinski T, Friedrich S. Distribution and expression of macrolide resistance genes in coagulase-negative staphylococci. Clin Microbiol Infect. 2007;13(8):777–781. doi:10.1111/j.1469-0691.2007.01749.x17501977
   PubMed Web of Science ®Google Scholar
• Gu B, Kelesidis T, Tsiodras S, Hindler J, Humphries RM. The emerging problem of linezolid-resistant staphylococcus. J Antimicrob Chemother. 2013;68(1):4–11. doi:10.1093/jac/dks35422949625
   PubMed Web of Science ®Google Scholar
• Bush K, Jacoby GA. Updated functional classification of β-lactamases. Antimicrob Agents Chemother. 2010;54(3):969–976. doi:10.1128/AAC.01009-0919995920
   PubMed Web of Science ®Google Scholar
• Khan AU. Medicine at nanoscale: a new horizon. Int J Nanomedicine. 2012;7:2997. doi:10.2147/IJN.S3323822787395
   PubMed Web of Science ®Google Scholar
• Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010;10(9):597–602. doi:10.1016/S1473-3099(10)70143-220705517
   PubMed Web of Science ®Google Scholar
• Wright GD. Bacterial resistance to antibiotics: enzymatic degradation and modification. Adv Drug Deliv Rev. 2005;57(10):1451–1470. doi:10.1016/j.addr.2005.04.00215950313
   PubMed Web of Science ®Google Scholar
• Robicsek A, Strahilevitz J, Jacoby GA, et al. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat Med. 2006;12(1):83–88. doi:10.1038/nm134716369542
   PubMed Web of Science ®Google Scholar
• Ponce CA, Chabé M, George C, et al. High prevalence of pneumocystis jirovecii dihydropteroate synthase gene mutations in patients with a first episode of pneumocystis pneumonia in Santiago, Chile, and clinical response to trimethoprim-sulfamethoxazole therapy. Antimicrob Agents Chemother. 2017;61(2):e01290–16. doi:10.1128/AAC.01290-1627855071
   PubMed Web of Science ®Google Scholar
• Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52(3):e18–e55.21208910
   PubMed Web of Science ®Google Scholar
• Helaine S, Kugelberg E. Bacterial persisters: formation, eradication, and experimental systems. Trends Microbiol. 2014;22(7):417–424. doi:10.1016/j.tim.2014.03.00824768561
   PubMed Web of Science ®Google Scholar
• Conlon BP, Nakayasu ES, Fleck LE, et al. Activated ClpP kills persisters and eradicates a chronic biofilm infection. Nature. 2013;503(7476):365–370. doi:10.1038/nature1279024226776
   PubMed Web of Science ®Google Scholar
• Arciola CR, Campoccia D, Montanaro L. Implant infections: adhesion, biofilm formation and immune evasion. Nat Rev Microbiol. 2018;16(7):397. doi:10.1038/s41579-018-0019-y29720707
   PubMed Web of Science ®Google Scholar
• Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet. 2001;358(9276):135–138. doi:10.1016/S0140-6736(01)05321-111463434
   PubMed Web of Science ®Google Scholar
• Hoffman LR, D’Argenio DA, MacCoss MJ, Zhang Z, Jones RA, Miller SI. Aminoglycoside antibiotics induce bacterial biofilm formation. Nature. 2005;436(7054):1171–1175. doi:10.1038/nature0391216121184
   PubMed Web of Science ®Google Scholar
• Gunn JS, Bakaletz LO, Wozniak DJ. What’s on the outside matters: the role of the extracellular polymeric substance of gram-negative biofilms in evading host immunity and as a target for therapeutic intervention. J Biol Chem. 2016;291(24):12538–12546. doi:10.1074/jbc.R115.70754727129225
   PubMed Web of Science ®Google Scholar
• Ferreira C, Pereira AM, Melo LF, Simões M. Advances in industrial biofilm control with micro-nanotechnology. Curr Res Technol Educ Top Appl Microbiol Microb Biotechnol. 2010;2:845–854.
   Google Scholar
• Fulaz S, Vitale S, Quinn L, Casey E. Nanoparticle–biofilm interactions: the role of the EPS matrix. Trends Microbiol. 2019;27(11):915–926. doi:10.1016/j.tim.2019.07.00431420126
   PubMed Web of Science ®Google Scholar
• DeLeon S, Clinton A, Fowler H, Everett J, Horswill AR, Rumbaugh KP. Synergistic interactions of pseudomonas aeruginosa and staphylococcus aureus in an in vitro wound model. Infect Immun. 2014;82(11):4718–4728. doi:10.1128/IAI.02198-1425156721
   PubMed Web of Science ®Google Scholar
• Kearns DB. A field guide to bacterial swarming motility. Nat Rev Microbiol. 2010;8(9):634–644. doi:10.1038/nrmicro240520694026
   PubMed Web of Science ®Google Scholar
• Lai S, Tremblay J, Déziel E. Swarming motility: a multicellular behaviour conferring antimicrobial resistance. Environ Microbiol. 2009;11(1):126–136. doi:10.1111/j.1462-2920.2008.01747.x18793317
   PubMed Web of Science ®Google Scholar
• Pelgrift RY, Friedman AJ. Nanotechnology as a therapeutic tool to combat microbial resistance. Adv Drug Deliv Rev. 2013;65(13–14):1803–1815. doi:10.1016/j.addr.2013.07.01123892192
   PubMed Web of Science ®Google Scholar
• Liu Y, Shi L, Su L, et al. Nanotechnology-based antimicrobials and delivery systems for biofilm-infection control. Chem Soc Rev. 2019;48(2):428–446. doi:10.1039/C7CS00807D30601473
   PubMed Web of Science ®Google Scholar
• Munir MU, Ihsan A, Sarwar Y, et al. Hollow mesoporous hydroxyapatite nanostructures; smart nanocarriers with high drug loading and controlled releasing features. Int J Pharm. 2018;544(1):112–120. doi:10.1016/j.ijpharm.2018.04.029.29678543
   PubMed Web of Science ®Google Scholar
• Kaur A, Preet S, Kumar V, Kumar R, Kumar R. Synergetic effect of vancomycin loaded silver nanoparticles for enhanced antibacterial activity. Colloids Surf B Biointerfaces. 2019;176:62–69. doi:10.1016/j.colsurfb.2018.12.04330594704
   PubMed Web of Science ®Google Scholar
• Pant J, Goudie MJ, Hopkins SP, Brisbois EJ, Handa H. Tunable nitric oxide release from s-nitroso-n-acetylpenicillamine via catalytic copper nanoparticles for biomedical applications. ACS Appl Mater Interfaces. 2017;9(18):15254–15264. doi:10.1021/acsami.7b0140828409633
   PubMed Web of Science ®Google Scholar
• Wang L, Hu C, Shao L. The-antimicrobial-activity-of-nanoparticles–present-situation. Int J Nanomedicine. 2017;12:1227–1249. doi:10.2147/IJN.S121956.28243086
   PubMed Web of Science ®Google Scholar
• Nguyen T-K, Selvanayagam R, Ho KKK, et al. Co-delivery of nitric oxide and antibiotic using polymeric nanoparticles. Chem Sci. 2016;7(2):1016–1027. doi:10.1039/C5SC02769A28808526
   PubMed Web of Science ®Google Scholar
• Dolanský J, Henke P, Malá Z, Žárská L, Kubát P, Mosinger J. Antibacterial nitric oxide-and singlet oxygen-releasing polystyrene nanoparticles responsive to light and temperature triggers. Nanoscale. 2018;10(5):2639–2648. doi:10.1039/C7NR08822A29355861
   PubMed Web of Science ®Google Scholar
• Privett BJ, Broadnax AD, Bauman SJ, Riccio DA, Schoenfisch MH. Examination of bacterial resistance to exogenous nitric oxide. Nitric Oxide. 2012;26(3):169–173. doi:10.1016/j.niox.2012.02.00222349019
   PubMed Web of Science ®Google Scholar
• Hall JR, Rouillard KR, Suchyta DJ, Brown MD, Ahonen MJR, Schoenfisch MH. Mode of nitric oxide delivery affects antibacterial action. ACS Biomater Sci Eng. 2019.
   PubMed Web of Science ®Google Scholar
• Schairer DO, Chouake JS, Nosanchuk JD, Friedman AJ. The potential of nitric oxide releasing therapies as antimicrobial agents. Virulence. 2012;3(3):271–279. doi:10.4161/viru.2032822546899
   PubMed Web of Science ®Google Scholar
• Rosen J, Landriscina A, Nosanchuk JD. Nitric oxide–releasing nanoparticles as an antimicrobial therapeutic In: Nanoscience in Dermatology. Elsevier; 2016;pp 127–134.
   Google Scholar
• Mousavi SA, Ghotaslou R, Kordi S, et al. Antibacterial and antifungal effects of chitosan nanoparticles on tissue conditioners of complete dentures. Int J Biol Macromol. 2018;118:881–885. doi:10.1016/j.ijbiomac.2018.06.15129964105
   PubMed Web of Science ®Google Scholar
• Yang J, Lu H, Li M, et al. Development of chitosan-sodium phytate nanoparticles as a potent antibacterial agent. Carbohydr Polym. 2017;178:311–321. doi:10.1016/j.carbpol.2017.09.05329050599
   PubMed Web of Science ®Google Scholar
• Hosseinnejad M, Jafari SM. Evaluation of different factors affecting antimicrobial properties of chitosan. Int J Biol Macromol. 2016;85:467–475. doi:10.1016/j.ijbiomac.2016.01.02226780706
   PubMed Web of Science ®Google Scholar
• Ma Z, Garrido-Maestu A, Jeong KC. Application, mode of action, and in vivo activity of chitosan and its micro-and nanoparticles as antimicrobial agents: a review. Carbohydr Polym. 2017;176:257–265. doi:10.1016/j.carbpol.2017.08.08228927606
   PubMed Web of Science ®Google Scholar
• Wassel MO, Khattab MA. Antibacterial activity against streptococcus mutans and inhibition of bacterial induced enamel demineralization of propolis, miswak, and chitosan nanoparticles based dental varnishes. J Adv Res. 2017;8(4):387–392. doi:10.1016/j.jare.2017.05.00628560054
   PubMed Web of Science ®Google Scholar
• Shi Z, Neoh KG, Kang ET, Wang W. Antibacterial and mechanical properties of bone cement impregnated with chitosan nanoparticles. Biomaterials. 2006;27(11):2440–2449. doi:10.1016/j.biomaterials.2005.11.03616338001
   PubMed Web of Science ®Google Scholar
• Wang JJ, Zeng ZW, Xiao RZ, et al. Recent advances of chitosan nanoparticles as drug carriers. Int J Nanomedicine. 2011;6:765. doi:10.2147/IJN.S2564621589644
   PubMed Web of Science ®Google Scholar
• Chen F, Shi Z, Neoh KG, Kang ET. Antioxidant and antibacterial activities of eugenol and carvacrol‐grafted chitosan nanoparticles. Biotechnol Bioeng. 2009;104(1):30–39. doi:10.1002/bit.2236319408318
   PubMed Web of Science ®Google Scholar
• Marangon CA, Martins VCA, Ling MH, et al. Combination of rhamnolipid and chitosan in nanoparticles boosts their antimicrobial efficacy. ACS Appl Mater Interfaces. 2020;12(5):5488–5499. doi:10.1021/acsami.9b19253.31927982
   PubMed Web of Science ®Google Scholar
• Wyszogrodzka G, Marszałek B, Gil B, Dorożyński P. Metal-organic frameworks: mechanisms of antibacterial action and potential applications. Drug Discov Today. 2016;21(6):1009–1018. doi:10.1016/j.drudis.2016.04.00927091434
   PubMed Web of Science ®Google Scholar
• Luo Y, Hossain M, Wang C, et al. Targeted nanoparticles for enhanced x-ray radiation killing of multidrug-resistant bacteria. Nanoscale. 2013;5(2):687–694. doi:10.1039/C2NR33154C23223782
   PubMed Web of Science ®Google Scholar
• Qiu Z, Yu Y, Chen Z, et al. Nanoalumina promotes the horizontal transfer of multiresistance genes mediated by plasmids across genera. Proc Natl Acad Sci. 2012;109(13):4944–4949. doi:10.1073/pnas.110725410922411796
   PubMed Web of Science ®Google Scholar
• Ramalingam B, Parandhaman T, Das SK. Antibacterial effects of biosynthesized silver nanoparticles on surface ultrastructure and nanomechanical properties of gram-negative bacteria viz. escherichia coli and pseudomonas aeruginosa. ACS Appl Mater Interfaces. 2016;8(7):4963–4976. doi:10.1021/acsami.6b0016126829373
   PubMed Web of Science ®Google Scholar
• Dakal TC, Kumar A, Majumdar RS, Yadav V. Mechanistic basis of antimicrobial actions of silver nanoparticles. Front Microbiol. 2016;7:1831. doi:10.3389/fmicb.2016.0183127899918
   PubMed Web of Science ®Google Scholar
• Song Z, Wu Y, Wang H, Han H. Synergistic antibacterial effects of curcumin modified silver nanoparticles through ROS-mediated pathways. Mater Sci Eng C. 2019;99:255–263. doi:10.1016/j.msec.2018.12.053
   PubMed Web of Science ®Google Scholar
• Acharya D, Singha KM, Pandey P, Mohanta B, Rajkumari J, Singha LP. Shape dependent physical mutilation and lethal effects of silver nanoparticles on bacteria. Sci Rep. 2018;8(1):201. doi:10.1038/s41598-017-18590-629317760
   PubMedGoogle Scholar
• Mahmoudi M, Serpooshan V. Silver-coated engineered magnetic nanoparticles are promising for the success in the fight against antibacterial resistance threat. ACS Nano. 2012;6(3):2656–2664. doi:10.1021/nn300042m22397679
   PubMed Web of Science ®Google Scholar
• Brown AN, Smith K, Samuels TA, Lu J, Obare SO, Scott ME. Nanoparticles functionalized with ampicillin destroy multiple-antibiotic-resistant isolates of pseudomonas aeruginosa and enterobacter aerogenes and methicillin-resistant staphylococcus aureus. Appl Environ Microbiol. 2012;78(8):2768–2774. doi:10.1128/AEM.06513-1122286985
   PubMed Web of Science ®Google Scholar
• Cheon JY, Kim SJ, Rhee YH, Kwon OH, Park WH. Shape-dependent antimicrobial activities of silver nanoparticles. Int J Nanomedicine. 2019;14:2773. doi:10.2147/IJN.S19647231118610
   PubMed Web of Science ®Google Scholar
• Hu Z, Zhang L, Zhong L, Zhou Y, Xue J, Li Y. Preparation of an antibacterial chitosan-coated biochar-nanosilver composite for drinking water purification. Carbohydr Polym. 2019;219:290–297. doi:10.1016/j.carbpol.2019.05.01731151528
   PubMed Web of Science ®Google Scholar
• Liu Z, Wang Y, Zu Y, et al. Synthesis of polyethylenimine (PEI) functionalized silver nanoparticles by a hydrothermal method and their antibacterial activity study. Mater Sci Eng C. 2014;42:31–37. doi:10.1016/j.msec.2014.05.007
   PubMed Web of Science ®Google Scholar
• Zhao R, Lv M, Li Y, et al. Stable nanocomposite based on pegylated and silver nanoparticles loaded graphene oxide for long-term antibacterial activity. ACS Appl Mater Interfaces. 2017;9(18):15328–15341. doi:10.1021/acsami.7b0398728422486
   PubMed Web of Science ®Google Scholar
• Durán N, Durán M, De Jesus MB, Seabra AB, Fávaro WJ, Nakazato G. Silver nanoparticles: a new view on mechanistic aspects on antimicrobial activity. Nanomed Nanotechnol. 2016;12(3):789–799. doi:10.1016/j.nano.2015.11.016
   PubMed Web of Science ®Google Scholar
• Wang L, Zhang T, Li P, et al. Use of synchrotron radiation-analytical techniques to reveal chemical origin of silver-nanoparticle cytotoxicity. ACS Nano. 2015;9(6):6532–6547.25994391
   PubMed Web of Science ®Google Scholar
• Khorrami S, Zarrabi A, Khaleghi M, Danaei M, Mozafari MR. Selective cytotoxicity of green synthesized silver nanoparticles against the MCF-7 tumor cell line and their enhanced antioxidant and antimicrobial properties. Int J Nanomedicine. 2018;13:8013. doi:10.2147/IJN.S18929530568442
   PubMed Web of Science ®Google Scholar
• Alavi M, Karimi N, Valadbeigi T. Antibacterial, antibiofilm, antiquorum sensing, antimotility, and antioxidant activities of green fabricated Ag, Cu, TiO2, ZnO, and Fe3O4 NPs via protoparmeliopsis muralis lichen aqueous extract against multi-drug-resistant bacteria. ACS Biomater Sci Eng. 2019;5(9):4228–4243. doi:10.1021/acsbiomaterials.9b00274
   PubMed Web of Science ®Google Scholar
• Kim JS, Kuk E, Yu KN, et al. Antimicrobial effects of silver nanoparticles. Nanomed Nanotechnol. 2007;3(1):95–101. doi:10.1016/j.nano.2006.12.001
   PubMed Web of Science ®Google Scholar
• Wang Y, Ding X, Chen Y, et al. Antibiotic-loaded, silver core-embedded mesoporous silica nanovehicles as a synergistic antibacterial agent for the treatment of drug-resistant infections. Biomaterials. 2016;101:207–216. doi:10.1016/j.biomaterials.2016.06.00427294538
   PubMed Web of Science ®Google Scholar
• Mottais A, Berchel M, Le Gall T, Sibiril Y. Antibacterial and transfection activities of nebulized formulations incorporating long n-alkyl chain silver n-heterocyclic carbene complexes. Int J Pharm. 2019;567:118500. doi:10.1016/j.ijpharm.2019.11850031288056
   PubMedGoogle Scholar
• Rai M, Deshmukh SD, Ingle AP, Gupta IR, Galdiero M, Galdiero S. The protective nanoshield against virus infection. Crit Rev Microbiol. 2016;42(1):46–56. doi:10.3109/1040841X.2013.87984924754250
   PubMed Web of Science ®Google Scholar
• Sirelkhatim A, Mahmud S, Seeni A, et al. Review on zinc oxide nanoparticles: antibacterial activity and toxicity mechanism. Nano-Micro Lett. 2015;7(3):219–242. doi:10.1007/s40820-015-0040-x
   PubMed Web of Science ®Google Scholar
• Mishra PK, Mishra H, Ekielski A, Talegaonkar S, Vaidya B. Zinc oxide nanoparticles: a promising nanomaterial for biomedical applications. Drug Discov Today. 2017;22(12):1825–1834. doi:10.1016/j.drudis.2017.08.00628847758
   PubMed Web of Science ®Google Scholar
• Siddiqi KS, Ur Rahman A, Husen A. Properties of zinc oxide nanoparticles and their activity against microbes. Nanoscale Res Lett. 2018;13(1):1–13. doi:10.1186/s11671-018-2532-329299709
   PubMedGoogle Scholar
• Król A, Pomastowski P, Rafińska K, Railean-Plugaru V, Buszewski B. Zinc oxide nanoparticles: synthesis, antiseptic activity and toxicity mechanism. Adv Colloid Interfac Sci. 2017;249:37–52. doi:10.1016/j.cis.2017.07.033
   PubMed Web of Science ®Google Scholar
• Kadiyala U, Turali-Emre ES, Bahng JH, Kotov NA, VanEpps JS. Unexpected insights into antibacterial activity of zinc oxide nanoparticles against methicillin resistant staphylococcus aureus (MRSA). Nanoscale. 2018;10(10):4927–4939. doi:10.1039/C7NR08499D29480295
   PubMed Web of Science ®Google Scholar
• Ramani M, Ponnusamy S, Muthamizhchelvan C. From zinc oxide nanoparticles to microflowers: a study of growth kinetics and biocidal activity. Mater Sci Eng C. 2012;32(8):2381–2389. doi:10.1016/j.msec.2012.07.011
   Web of Science ®Google Scholar
• Pati R, Mehta RK, Mohanty S, et al. Topical application of zinc oxide nanoparticles reduces bacterial skin infection in mice and exhibits antibacterial activity by inducing oxidative stress response and cell membrane disintegration in macrophages. Nanomed Nanotechnol. 2014;10(6):1195–1208. doi:10.1016/j.nano.2014.02.012
   PubMed Web of Science ®Google Scholar
• Meghana S, Kabra P, Chakraborty S, Padmavathy N. Understanding the pathway of antibacterial activity of copper oxide nanoparticles. RSC Adv. 2015;5(16):12293–12299. doi:10.1039/C4RA12163E
   Web of Science ®Google Scholar
• Hassan MS, Amna T, Yang O-B, El-Newehy MH, Al-Deyab SS, Khil M-S. Smart copper oxide nanocrystals: synthesis, characterization, electrochemical and potent antibacterial activity. Colloids Surf B Biointerfaces. 2012;97:201–206. doi:10.1016/j.colsurfb.2012.04.03222609604
   PubMed Web of Science ®Google Scholar
• Ananth A, Dharaneedharan S, Heo M-S, Mok YS. Copper oxide nanomaterials: synthesis, characterization and structure-specific antibacterial performance. Chem Eng J. 2015;262:179–188. doi:10.1016/j.cej.2014.09.083
   Web of Science ®Google Scholar
• Azam A, Ahmed AS, Oves M, Khan MS, Memic A. Size-dependent antimicrobial properties of CuO nanoparticles against gram-positive and-negative bacterial strains. Int J Nanomedicine. 2012;7:3527. doi:10.2147/IJN.S2902022848176
   PubMed Web of Science ®Google Scholar
• Laha D, Pramanik A, Laskar A, Jana M, Pramanik P, Karmakar P. Shape-dependent bactericidal activity of copper oxide nanoparticle mediated by DNA and membrane damage. Mater Res Bull. 2014;59:185–191. doi:10.1016/j.materresbull.2014.06.024
   Web of Science ®Google Scholar
• Li M, Gao L, Schlaich C, et al. Construction of functional coatings with durable and broad-spectrum antibacterial potential based on mussel-inspired dendritic polyglycerol and in situ-formed copper nanoparticles. ACS Appl Mater Interfaces. 2017;9(40):35411–35418. doi:10.1021/acsami.7b1054128914053
   PubMed Web of Science ®Google Scholar
• Ranjan S, Ramalingam C. Titanium dioxide nanoparticles induce bacterial membrane rupture by reactive oxygen species generation. Environ Chem Lett. 2016;14(4):487–494. doi:10.1007/s10311-016-0586-y
   Web of Science ®Google Scholar
• Huang -Y-Y, Choi H, Kushida Y, Bhayana B, Wang Y, Hamblin MR. Broad-spectrum antimicrobial effects of photocatalysis using titanium dioxide nanoparticles are strongly potentiated by addition of potassium iodide. Antimicrob Agents Chemother. 2016;60(9):5445–5453. doi:10.1128/AAC.00980-1627381399
   PubMed Web of Science ®Google Scholar
• Venkatasubbu GD, Baskar R, Anusuya T, Seshan CA, Chelliah R. Toxicity mechanism of titanium dioxide and zinc oxide nanoparticles against food pathogens. Colloids Surf B Biointerfaces. 2016;148:600–606. doi:10.1016/j.colsurfb.2016.09.04227694049
   PubMed Web of Science ®Google Scholar
• Chen S, Guo Y, Zhong H, et al. Synergistic antibacterial mechanism and coating application of copper/titanium dioxide nanoparticles. Chem Eng J. 2014;256:238–246. doi:10.1016/j.cej.2014.07.006
   Web of Science ®Google Scholar
• Brunet L, Lyon DY, Hotze EM, Alvarez PJJ, Wiesner MR. Comparative photoactivity and antibacterial properties of c60 fullerenes and titanium dioxide nanoparticles. Environ Sci Technol. 2009;43(12):4355–4360. doi:10.1021/es803093t19603646
   PubMed Web of Science ®Google Scholar
• Liu N, Chang Y, Feng Y, et al. {101}–{001} Surface heterojunction-enhanced antibacterial activity of titanium dioxide nanocrystals under sunlight irradiation. ACS Appl Mater Interfaces. 2017;9(7):5907–5915. doi:10.1021/acsami.6b1637328125216
   PubMed Web of Science ®Google Scholar
• Kalathil S, Khan MM, Ansari SA, Lee J, Cho MH. Band gap narrowing of titanium dioxide (TiO 2) nanocrystals by electrochemically active biofilms and their visible light activity. Nanoscale. 2013;5(14):6323–6326. doi:10.1039/c3nr01280h23760526
   PubMed Web of Science ®Google Scholar
• Ghosal K, Agatemor C, Špitálsky Z, Thomas S, Kny E. Electrospinning tissue engineering and wound dressing scaffolds from polymer-titanium dioxide nanocomposites. Chem Eng J. 2019;358:1262–1278. doi:10.1016/j.cej.2018.10.117
   Web of Science ®Google Scholar
• Wolfrum EJ, Huang J, Blake DM, et al. Photocatalytic oxidation of bacteria, bacterial and fungal spores, and model biofilm components to carbon dioxide on titanium dioxide-coated surfaces. Environ Sci Technol. 2002;36(15):3412–3419. doi:10.1021/es011423j12188373
   PubMed Web of Science ®Google Scholar
• Dahl M, Liu Y, Yin Y. Composite titanium dioxide nanomaterials. Chem Rev. 2014;114(19):9853–9889. doi:10.1021/cr400634p25011918
   PubMed Web of Science ®Google Scholar
• Blecher K, Nasir A, Friedman A. The growing role of nanotechnology in combating infectious disease. Virulence. 2011;2(5):395–401. doi:10.4161/viru.2.5.1703521921677
   PubMed Web of Science ®Google Scholar
• Lellouche J, Friedman A, Lahmi R, Gedanken A, Banin E. Antibiofilm surface functionalization of catheters by magnesium fluoride nanoparticles. Int J Nanomedicine. 2012;7:1175. doi:10.2147/IJN.S3063122419866
   PubMed Web of Science ®Google Scholar
• Stoimenov PK, Klinger RL, Marchin GL, Klabunde KJ. Metal oxide nanoparticles as bactericidal agents. Langmuir. 2002;18(17):6679–6686. doi:10.1021/la0202374
   Web of Science ®Google Scholar
• Haggstrom JA, Klabunde KJ, Marchin GL. Biocidal properties of metal oxide nanoparticles and their halogen adducts. Nanoscale. 2010;2(3):399–405. doi:10.1039/B9NR00245F20644823
   PubMed Web of Science ®Google Scholar
• Shedbalkar U, Singh R, Wadhwani S, Gaidhani S, Chopade BA. Microbial synthesis of gold nanoparticles: current status and future prospects. Adv Colloid Interfac Sci. 2014;209:40–48. doi:10.1016/j.cis.2013.12.011
   PubMed Web of Science ®Google Scholar
• Suresh AK, Pelletier DA, Wang W, et al. Biofabrication of discrete spherical gold nanoparticles using the metal-reducing bacterium shewanella oneidensis. Acta Biomater. 2011;7(5):2148–2152. doi:10.1016/j.actbio.2011.01.02321241833
   PubMed Web of Science ®Google Scholar
• Rai A, Prabhune A, Perry CC. Antibiotic mediated synthesis of gold nanoparticles with potent antimicrobial activity and their application in antimicrobial coatings. J Mater Chem. 2010;20(32):6789–6798. doi:10.1039/c0jm00817f
   Web of Science ®Google Scholar
• Feng Y, Chen W, Jia Y, et al. N-Heterocyclic molecule-capped gold nanoparticles as effective antibiotics against multi-drug resistant bacteria. Nanoscale. 2016;8(27):13223–13227. doi:10.1039/C6NR03317B27355451
   PubMed Web of Science ®Google Scholar
• Zhao Y, Jiang X. Multiple strategies to activate gold nanoparticles as antibiotics. Nanoscale. 2013;5(18):8340–8350. doi:10.1039/c3nr01990j23893008
   PubMed Web of Science ®Google Scholar
• Bagga P, Hussain Siddiqui H, Akhtar J, Mahmood T, Zahera M, Sajid Khan M. Gold nanoparticles conjugated levofloxacin: for improved antibacterial activity over levofloxacin alone. Curr Drug Deliv. 2017;14(8):1114–1119. doi:10.2174/156720181466617031611343228302030
   PubMed Web of Science ®Google Scholar
• Payne JN, Waghwani HK, Connor MG, et al. Novel synthesis of kanamycin conjugated gold nanoparticles with potent antibacterial activity. Front Microbiol. 2016;7:607. doi:10.3389/fmicb.2016.0060727330535
   PubMed Web of Science ®Google Scholar
• Cui Y, Zhao Y, Tian Y, Zhang W, Lü X, Jiang X. The molecular mechanism of action of bactericidal gold nanoparticles on escherichia coli. Biomaterials. 2012;33(7):2327–2333. doi:10.1016/j.biomaterials.2011.11.05722182745
   PubMed Web of Science ®Google Scholar
• Gu H, Ho PL, Tong E, Wang L, Xu B. Presenting vancomycin on nanoparticles to enhance antimicrobial activities. Nano Lett. 2003;3(9):1261–1263. doi:10.1021/nl034396z
   Web of Science ®Google Scholar
• Pornpattananangkul D, Zhang L, Olson S, et al. Bacterial toxin-triggered drug release from gold nanoparticle-stabilized liposomes for the treatment of bacterial infection. J Am Chem Soc. 2011;133(11):4132–4139. doi:10.1021/ja111110e21344925
   PubMed Web of Science ®Google Scholar
• Pillai PP, Kowalczyk B, Kandere-Grzybowska K, Borkowska M, Grzybowski BA. Engineering gram selectivity of mixed-charge gold nanoparticles by tuning the balance of surface charges.Angew Chem Int Ed. 2016;55(30):8610–8614. doi:10.1002/anie.201602965
   PubMed Web of Science ®Google Scholar
• Hernandez-Delgadillo R, Velasco-Arias D, Diaz D, et al. Zerovalent bismuth nanoparticles inhibit streptococcus mutans growth and formation of biofilm. Int J Nanomedicine. 2012;7:2109.22619547
   PubMedGoogle Scholar
• Zhao Y, Zhang Z, Dang H. A simple way to prepare bismuth nanoparticles. Mater Lett. 2004;58(5):790–793. doi:10.1016/j.matlet.2003.07.013
   Web of Science ®Google Scholar
• Wang F, Tang R, Yu H, Gibbons PC, Buhro WE. Size-and shape-controlled synthesis of bismuth nanoparticles. Chem Mater. 2008;20(11):3656–3662. doi:10.1021/cm8004425
   Web of Science ®Google Scholar
• Gao W, Thamphiwatana S, Angsantikul P, Zhang L. Nanoparticle approaches against bacterial infections. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2014;6(6):532–547. doi:10.1002/wnan.128225044325
   PubMed Web of Science ®Google Scholar
• Sadiq IM, Chowdhury B, Chandrasekaran N, Mukherjee A. Antimicrobial sensitivity of escherichia coli to alumina nanoparticles. Nanomed Nanotechnol. 2009;5(3):282–286. doi:10.1016/j.nano.2009.01.002
   PubMed Web of Science ®Google Scholar
• Ji H, Sun H, Qu X. Antibacterial applications of graphene-based nanomaterials: recent achievements and challenges. Adv Drug Deliv Rev. 2016;105:176–189. doi:10.1016/j.addr.2016.04.00927129441
   PubMed Web of Science ®Google Scholar
• Xia M-Y, Xie Y, Yu C-H, et al. Graphene-based nanomaterials: the promising active agents for antibiotics-independent antibacterial applications. J Control Release. 2019;307:16–31. doi:10.1016/j.jconrel.2019.06.01131185232
   PubMed Web of Science ®Google Scholar
• Hu W, Peng C, Luo W, et al. Graphene-based antibacterial paper. ACS Nano. 2010;4(7):4317–4323. doi:10.1021/nn101097v20593851
   PubMed Web of Science ®Google Scholar
• Akhavan O, Ghaderi E. Toxicity of graphene and graphene oxide nanowalls against bacteria. ACS Nano. 2010;4(10):5731–5736. doi:10.1021/nn101390x20925398
   PubMed Web of Science ®Google Scholar
• Paszkiewicz S, Szymczyk A. Graphene-based nanomaterials and their polymer nanocomposites In: Nanomaterials and Polymer Nanocomposites. Elsevier; 2019:pp 177–216.
   Google Scholar
• Shaker MA, Shaaban MI. Formulation of carbapenems loaded gold nanoparticles to combat multi-antibiotic bacterial resistance: in vitro antibacterial study. Int J Pharm. 2017;525(1):71–84. doi:10.1016/j.ijpharm.2017.04.01928411141
   PubMedGoogle Scholar
• Xu J, Xu B, Shou D, Xia X, Hu Y. Preparation and evaluation of vancomycin-loaded N-trimethyl chitosan nanoparticles. Polymers (Basel). 2015;7(9):1850–1870. doi:10.3390/polym7091488
   Web of Science ®Google Scholar
• Tom RT, Suryanarayanan V, Reddy PG, Baskaran S, Pradeep T. Ciprofloxacin-protected gold nanoparticles. Langmuir. 2004;20(5):1909–1914. doi:10.1021/la035856715801462
   PubMed Web of Science ®Google Scholar
• Friedman AJ, Phan J, Schairer DO, et al. Antimicrobial and anti-inflammatory activity of chitosan–alginate nanoparticles: a targeted therapy for cutaneous pathogens. J Invest Dermatol. 2013;133(5):1231–1239. doi:10.1038/jid.2012.39923190896
   PubMed Web of Science ®Google Scholar
• Yoksan R, Chirachanchai S. Silver nanoparticle-loaded chitosan–starch based films: fabrication and evaluation of tensile, barrier and antimicrobial properties. Mater Sci Eng C. 2010;30(6):891–897. doi:10.1016/j.msec.2010.04.004
   Web of Science ®Google Scholar
• Smith AW. Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems? Adv Drug Deliv Rev. 2005;57(10):1539–1550. doi:10.1016/j.addr.2005.04.00715950314
   PubMed Web of Science ®Google Scholar
• Zhao Y, Dai X, Wei X, et al. Near-infrared light-activated thermosensitive liposomes as efficient agents for photothermal and antibiotic synergistic therapy of bacterial biofilm. ACS Appl Mater Interfaces. 2018;10(17):14426–14437. doi:10.1021/acsami.8b0132729651836
   PubMed Web of Science ®Google Scholar
• Gonzalez Gomez A, Xu C, Hosseinidoust Z. Preserving the efficacy of glycopeptide antibiotics during nanoencapsulation in liposomes. ACS Infect Dis. 2019;5(10):1794–1801. doi:10.1021/acsinfecdis.9b0023231397146
   PubMed Web of Science ®Google Scholar
• Pushparaj Selvadoss P, Nellore J, Balaraman Ravindrran M, Sekar U. Novel pyochelin-based pegylated liposomes for enhanced delivery of antibiotics against resistant clinical isolates of pseudomonas aeruginosa. Artif Cells Nanomed Biotechnol. 2018;46(8):2043–2053.29179607
   PubMed Web of Science ®Google Scholar
• Obonyo M, Zhang L, Thamphiwatana S, Pornpattananangkul D, Fu V, Zhang L. Antibacterial activities of liposomal linolenic acids against antibiotic-resistant helicobacter pylori. Mol Pharm. 2012;9(9):2677–2685. doi:10.1021/mp300243w22827534
   PubMedGoogle Scholar
• Yuan Z, Tam VH. Polymyxin B: a new strategy for multidrug-resistant gram-negative organisms. Expert Opin Investig Drugs. 2008;17(5):661–668. doi:10.1517/13543784.17.5.661
   PubMed Web of Science ®Google Scholar
• Rukavina Z, Vanić Ž. Current trends in development of liposomes for targeting bacterial biofilms. Pharmaceutics. 2016;8(2):18. doi:10.3390/pharmaceutics8020018
   PubMed Web of Science ®Google Scholar
• Inoue K. Functional dendrimers, hyperbranched and star polymers. Prog Polym Sci. 2000;25(4):453–571. doi:10.1016/S0079-6700(00)00011-3
   Web of Science ®Google Scholar
• Mignani SM, El Brahmi N, El Kazzouli S. Original multivalent gold (III) and dual gold (III)–copper (II) conjugated phosphorus dendrimers as potent antitumoral and antimicrobial agents. Mol Pharm. 2017;14(11):4087–4097. doi:10.1021/acs.molpharmaceut.7b0077128960997
   PubMedGoogle Scholar
• Balogh L, Swanson DR, Tomalia DA, Hagnauer GL, McManus AT. Dendrimer− silver complexes and nanocomposites as antimicrobial agents. Nano Lett. 2001;1(1):18–21. doi:10.1021/nl005502p
   Web of Science ®Google Scholar
• Hetrick EM, Shin JH, Paul HS, Schoenfisch MH. Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles. Biomaterials. 2009;30(14):2782–2789. doi:10.1016/j.biomaterials.2009.01.05219233464
   PubMed Web of Science ®Google Scholar
• Roe D, Karandikar B, Bonn-Savage N, Gibbins B, Roullet J-B. Antimicrobial surface functionalization of plastic catheters by silver nanoparticles. J Antimicrob Chemother. 2008;61(4):869–876. doi:10.1093/jac/dkn03418305203
   PubMed Web of Science ®Google Scholar
• Sapsford KE, Algar WR, Berti L, et al. Functionalizing nanoparticles with biological molecules: developing chemistries that facilitate nanotechnology. Chem Rev. 2013;113(3):1904–2074. doi:10.1021/cr300143v23432378
   PubMed Web of Science ®Google Scholar
• Bing W, Chen Z, Sun H, et al. Visible-light-driven enhanced antibacterial and biofilm elimination activity of graphitic carbon nitride by embedded Ag nanoparticles. Nano Res. 2015;8(5):1648–1658. doi:10.1007/s12274-014-0654-1
   Web of Science ®Google Scholar
• Guo G, Zhou H, Wang Q, et al. Nano-layered magnesium fluoride reservoirs on biomaterial surfaces strengthen polymorphonuclear leukocyte resistance to bacterial pathogens. Nanoscale. 2017;9(2):875–892. doi:10.1039/C6NR07729C27995243
   PubMed Web of Science ®Google Scholar
• Geilich BM, Gelfat I, Sridhar S, van de Ven AL, Webster TJ. Superparamagnetic iron oxide-encapsulating polymersome nanocarriers for biofilm eradication. Biomaterials. 2017;119:78–85. doi:10.1016/j.biomaterials.2016.12.01128011336
   PubMed Web of Science ®Google Scholar
• Dinali R, Ebrahiminezhad A, Manley-Harris M, Ghasemi Y, Berenjian A. Iron oxide nanoparticles in modern microbiology and biotechnology. Crit Rev Microbiol. 2017;43(4):493–507. doi:10.1080/1040841X.2016.126770828068855
   PubMed Web of Science ®Google Scholar
• Anghel I, Grumezescu AM, Andronescu E, et al. Magnetite nanoparticles for functionalized textile dressing to prevent fungal biofilms development. Nanoscale Res Lett. 2012;7(1):501. doi:10.1186/1556-276X-7-50122950367
   PubMedGoogle Scholar
• Chifiriuc C, Grumezescu V, Grumezescu AM, Saviuc C, Lazăr V, Andronescu E. Hybrid magnetite nanoparticles/rosmarinus officinalis essential oil nanobiosystem with antibiofilm activity. Nanoscale Res Lett. 2012;7(1):209. doi:10.1186/1556-276X-7-20922490675
   PubMedGoogle Scholar
• Alavi M, Karimi N. Ultrasound assisted-phytofabricated fe3o4 NPS with antioxidant properties and antibacterial effects on growth, biofilm formation, and spreading ability of multidrug resistant bacteria. Artif Cells Nanomed Biotechnol. 2019;47(1):2405–2423. doi:10.1080/21691401.2019.162456031187647
   PubMed Web of Science ®Google Scholar
• Kim H, Jones MN. The delivery of benzyl penicillin to staphylococcus aureus biofilms by use of liposomes. J Liposome Res. 2004;14(3–4):123–139. doi:10.1081/LPR-20002988715676122
   PubMed Web of Science ®Google Scholar
• Huang C-M, Chen C-H, Pornpattananangkul D, et al. Eradication of drug resistant staphylococcus aureus by liposomal oleic acids. Biomaterials. 2011;32(1):214–221. doi:10.1016/j.biomaterials.2010.08.07620880576
   PubMed Web of Science ®Google Scholar
• Lee W-H, Loo C-Y, Traini D, Young PM. Nano-and micro-based inhaled drug delivery systems for targeting alveolar macrophages. Expert Opin Drug Deliv. 2015;12(6):1009–1026. doi:10.1517/17425247.2015.103950925912721
   PubMed Web of Science ®Google Scholar
• Kim B, Pang H-B, Kang J, Park J-H, Ruoslahti E, Sailor MJ. Immunogene therapy with fusogenic nanoparticles modulates macrophage response to staphylococcus aureus. Nat Commun. 2018;9(1):1–13. doi:10.1038/s41467-017-02088-w29317637
   PubMedGoogle Scholar
• Wang L, Hu C, Shao L. The antimicrobial activity of nanoparticles: present situation and prospects for the future. Int J Nanomedicine. 2017;12:1227. doi:10.2147/IJN.S12195628243086
   PubMed Web of Science ®Google Scholar
• Gao W, Chen Y, Zhang Y, Zhang Q, Zhang L. Nanoparticle-based local antimicrobial drug delivery. Adv Drug Deliv Rev. 2018;127:46–57. doi:10.1016/j.addr.2017.09.01528939377
   PubMed Web of Science ®Google Scholar
• Hindi KM, Ditto AJ, Panzner MJ, et al. The antimicrobial efficacy of sustained release silver–carbene complex-loaded l-tyrosine polyphosphate nanoparticles: characterization, in vitro and in vivo studies. Biomaterials. 2009;30(22):3771–3779. doi:10.1016/j.biomaterials.2009.03.04419395021
   PubMed Web of Science ®Google Scholar
• Graves JL, Thomas M, Ewunkem JA. Antimicrobial nanomaterials: why evolution matters. Nanomaterials. 2017;7(10):283. doi:10.3390/nano7100283
   Web of Science ®Google Scholar
• Ventola CL. Progress in nanomedicine: approved and investigational nanodrugs. Pharm Ther. 2017;42(12):742.
   Google Scholar
• Stankic S, Suman S, Haque F, Pure VJ. Multi metal oxide nanoparticles: synthesis, antibacterial and cytotoxic properties. J Nanobiotechnol. 2016;14(1):73. doi:10.1186/s12951-016-0225-6
   PubMedGoogle Scholar
• da Silva BL, Caetano BL, Chiari-Andréo BG, Pietro RCLR, Chiavacci LA. Increased antibacterial activity of ZnO nanoparticles: influence of size and surface modification. Colloids Surf B Biointerfaces. 2019;177:440–447. doi:10.1016/j.colsurfb.2019.02.01330798065
   PubMed Web of Science ®Google Scholar
• Munir MU, Ihsan A, Javed I, et al. Controllably biodegradable hydroxyapatite nanostructures for cefazolin delivery against antibacterial resistance. ACS Omega. 2019;4(4):7524–7532. doi:10.1021/acsomega.9b00541.
   Web of Science ®Google Scholar
• Zare EN, Makvandi P, Borzacchiello A, Tay FR, Ashtari B, Padil VVT. Antimicrobial gum bio-based nanocomposites and their industrial and biomedical applications. Chem Commun. 2019;55(99):14871–14885. doi:10.1039/C9CC08207G
   PubMed Web of Science ®Google Scholar
• Singh J, Dhaliwal AS. Synthesis, characterization and swelling behavior of silver nanoparticles containing superabsorbent based on grafted copolymer of polyacrylic acid/guar gum. Vacuum. 2018;157:51–60. doi:10.1016/j.vacuum.2018.08.017
   Web of Science ®Google Scholar
• Othman SH. Bio-nanocomposite materials for food packaging applications: types of biopolymer and nano-sized filler. Agric Sci Proc. 2014;2:296–303.
   Google Scholar
• Zare EN, Lakouraj MM, Mohseni M. Biodegradable polypyrrole/ dextrin conductive nanocomposite: synthesis, characterization, antioxidant and antibacterial activity. Synth Met. 2014;187:9–16.
   Web of Science ®Google Scholar